跳至主要内容
临床试验/CTRI/2025/02/080181
CTRI/2025/02/080181尚未招募不适用

A Randomized Controlled Clinical Study Of Siktha Haridradi Malahar (Ointment) In The Management Of Parikartika W.S.R. To Fissure In Ano

DR SHRINIVAS IRABATI1 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2025年2月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
106
试验地点
1
主要终点
Difference in the effect of trial drug in parikartika subjective criterias are pain

研究概览

简要总结

ANAL FISSURE COMPRISES OF AN ALARMING INCIDENCE RATE OF 12-15% AMONG DIFFERENT PROCTOLOGICAL PATHOLOGIES

THIS ALWAYS POINTS TOWARDS NEW FORMULATION TO MANAGE THE DISEASE EFFECTIVELY

HENCE SIKTHA HARIDRADI MALAHAR MENTIONED FOR PARIKARTIKA DISEASE IN RASATARANGINI 2/34

WE ARE ALSO ADDING SOME VRANAROPAN DRUGS AND PREPARE OWN SIKTHA HARIDRADI MALAHAR IN THE MANAGEMENT OF PARIKARTIKA

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from acute and chronic fissue in ano with presenting sign and symptoms eg pain anal spasm and per rectal bleeding burning sensation in ano constipation.
  • Pregnant and lactating female.
  • Patients having fissure in ano along with first and second degree hemorrhoids.
  • Patients having controlled diabetes mellitus hypertension on medication.

排除标准

  • Patients who are having systemic disease and immune compromised disease.
  • Patients who are having carcinoma of anus and rectum proctalgia fugax ulcerative collitis crohns disease fistula in ano perianal abscess and any other major illness.
  • Patients having hemoglobin less than 9 gm.

结局指标

主要结局

Difference in the effect of trial drug in parikartika subjective criterias are pain

时间窗: 4 Weeks

Anal ulcer

时间窗: 4 Weeks

Burning sensation

时间窗: 4 Weeks

Constipation

时间窗: 4 Weeks

Objective criterias are

时间窗: 4 Weeks

Spasm (resting pressure)

时间窗: 4 Weeks

Above parameters are assessed before and after treatment

时间窗: 4 Weeks

次要结局

  • REDUCTION IN SYMPTOMS OF PARIKARTIKA(1 MONTH)

研究者

发起方
DR SHRINIVAS IRABATI
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR. SHRINIVAS SHANKAR IRABATI

R A PODDAR AYURVED MEDICAL COLLEGE

研究点 (1)

Loading locations...

相似试验